In 2020, the omics technologies phase accounted for the biggest share of the market. Increase use of cancer biomarkers for new developments is driving the growth of the segment.Dependant on end person, the market is segmented into pharmaceutical & biotechnology providers, diagnostics & investigate laboratories, hospitals & specialty clinics and oth